Ligand Pharmaceuticals Inc
Nasdaq: LGND
- Raised $85 million (2016)
- 28 clinical trials
- Research grants: $71,588
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Biomerica Inc
Nasdaq: BMRA
- Raised $2 million (2020)
- 3 clinical trials
- FDA-cleared or approved devices
Acumen Pharmaceuticals, Inc.
Nasdaq: ABOS
- Raised $700,000 (2013)
- 3 clinical trials, 1 active
- Research grants: $950,053
NeuroPace Inc
Nasdaq: NPCE
- Raised $69 million (2020)
- 9 clinical trials, 2 active
- FDA-cleared or approved devices
Shockwave Medical, Inc.
- Raised $10 million (2019)
- 28 clinical trials, 7 active
- FDA-cleared or approved devices
Meridian Bioscience Inc
- 27 clinical trials
- FDA-cleared or approved devices
- Research grants: $606,251
Cyteir Therapeutics, Inc.
- Raised $80 million (2021)
- 1 clinical trial
- Research grants: $4.2 million
- Founded 2012
Venatorx Pharmaceuticals, Inc.
- Raised $35 million (2023)
- 8 clinical trials
- Research grants: $63 million
- Founded 2010
Precision Biosciences Inc
Nasdaq: DTIL
- Raised $40 million (2019)
- 6 clinical trials, 3 active
- Research grants: $502,296
Cumberland Pharmaceuticals Inc
Nasdaq: CPIX
- 49 clinical trials, 2 active
- Research grants: $6.9 million
Treace Medical Concepts, Inc.
Nasdaq: TMCI
- Raised $5.9 million (2017)
- 4 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2014
Palatin Technologies Inc
Nasdaq: PTN
- Raised $35 million (2012)
- 12 clinical trials, 2 active
- Research grants: $1.7 million
Apyx Medical Corp
Nasdaq: APYX
- Raised $7 million (2013)
- 11 clinical trials, 1 active
- FDA-cleared or approved devices
Journey Medical Corp
Nasdaq: DERM
- Raised $19 million (2021)
- 10 clinical trials
- FDA-cleared or approved devices
Vero Biotech Inc.
- Raised $27 million (2021)
- 1 FDA-registered device site
- 2 FDA-registered drug sites
- Research grants: $294,031
Biodesix Inc
Nasdaq: BDSX
- Raised $16 million (2020)
- 6 clinical trials, 3 active
- 1 FDA-registered device site
- Founded 2005
Vaccinex, Inc.
OTC: VCNX
- Raised $200,155 (2024)
- 7 clinical trials, 1 active
- Research grants: $4.4 million
Biomarin Pharmaceutical Inc
Nasdaq: BMRN
- 115 clinical trials, 29 active
- 1 FDA-registered drug site
- Research grants: $286,641
Imunon, Inc.
Nasdaq: IMNN
- Raised $3.3 million (2025)
- 15 clinical trials, 3 active
- 1 FDA-registered drug site
Caribou Biosciences, Inc.
Nasdaq: CRBU
- Raised $115 million (2021)
- 5 clinical trials, 2 active
- Research grants: $158,902
- Founded 2011
Vaxart, Inc.
OTC: VXRT
- Raised $20 million (2013)
- 24 clinical trials, 1 active
- Research grants: $3.4 million
Vivani Medical, Inc.
Nasdaq: VANI
- Raised $28 million (2021)
- 12 clinical trials, 2 active
- Research grants: $236,104
Imricor Medical Systems, Inc.
- Raised $613,079 (2019)
- 2 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $1.3 million
Shoulder Innovations, Inc.
NYSE: SI
- Raised $20 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
Cerus Corp
Nasdaq: CERS
- 17 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $3.5 million
SPR Therapeutics, Inc.
- Raised $26 million (2024)
- 10 clinical trials, 1 active
- Research grants: $24 million
- Founded 2009
Milestone Scientific Inc.
NYSE: MLSS
- Raised $2.1 million (2026)
- 1 clinical trial
- FDA-cleared or approved devices
Genvec Inc
- Raised $2 million (2010)
- 9 clinical trials
- Research grants: $12 million
Mirum Pharmaceuticals, Inc.
Nasdaq: MIRM
- Raised $68 million (2026)
- 39 clinical trials, 13 active
- Founded 2018
Clearside Biomedical, Inc.
OTC: CLSDQ
- Raised $3.3 million (2019)
- 14 clinical trials
- 1 FDA-registered device site
- Founded 2011
RxSight, Inc.
Nasdaq: RXST
- Raised $50 million (2017)
- 9 clinical trials, 1 active
- FDA-cleared or approved devices
Active Life Scientific, Inc.
- Raised $1 million (2020)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $11 million
Actuated Medical, Inc.
- Raised $150,000 (2012)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $70 million
Stereotaxis, Inc.
NYSE: STXS
- Raised $8.5 million (2012)
- 11 clinical trials, 2 active
- FDA-cleared or approved devices
Dxterity Diagnostics Inc
- Raised $106,250 (2021)
- 9 clinical trials
- 1 FDA-registered device site
- Research grants: $1.9 million
Exicure, Inc.
Nasdaq: XCUR
- Raised $22 million (2018)
- 2 clinical trials
- Research grants: $374,876
- Founded 2011
Imperative Care, Inc.
- Raised $100 million (2026)
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2015
Revbio, Inc.
- Raised $10 million (2025)
- 5 clinical trials, 4 active
- Research grants: $35 million
- Founded 2016
BioNTech SE
Nasdaq: BNTX
- Raised $150 million (2022)
- 103 clinical trials, 51 active
Collegium Pharmaceutical, Inc
Nasdaq: COLL
- Raised $20 million (2018)
- 1 clinical trial
- Research grants: $472,811
ImmunityBio, Inc.
Nasdaq: IBRX
- Raised $470 million (2023)
- 82 clinical trials, 21 active
Verona Pharma plc
- Raised $200 million (2020)
- 1 clinical trial
- Founded 2005
Zimmer Biomet Holdings, Inc.
NYSE: ZBH
- Raised $216 million (2023)
- 278 clinical trials, 65 active
Aspira Women's Health Inc.
OTC: AWHL
- Raised $1.5 million (2026)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
Bone Health Technologies, Inc.
- Raised $3.2 million (2023)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $5.4 million
EndoTheia, Inc.
- Raised $500,000 (2024)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $12 million
Hydrocision Inc
- Raised $2.5 million (2025)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $600,000
Novavax Inc
Nasdaq: NVAX
- 49 clinical trials, 1 active
- 2 FDA-registered drug sites
- Research grants: $246,812
Adynxx, Inc.
- Raised $2.8 million (2017)
- 6 clinical trials
- Research grants: $1.2 million
- Founded 2007
Iovance Biotherapeutics, Inc.
Nasdaq: IOVA
- Raised $100 million (2016)
- 16 clinical trials, 9 active
- 1 FDA-registered drug site
- Founded 2007
Published company profiles only; counts update daily. Data licences